Company Search:
Advanced Search
Sponsored Links
Dr.Reddy's Laboratories Ltd Company Snapshot
Dr.Reddy's Laboratories Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dr.Reddy's Laboratories Ltd with three other companies in this sector in India: Cadila Healthcare Ltd (2016 sales of 98.38 billion Indian Rupees [US$1.50 billion] of which 100% was Pharmaceutical Products), Aurobindo Pharma Ltd (138.96 billion Indian Rupees [US$2.12 billion] of which 100% was Pharmaceuticals), and Cipla Ltd (136.78 billion Indian Rupees [US$2.09 billion] of which 100% was Pharmaceutical Preparation).

Sales Analysis. Dr.Reddy's Laboratories Ltd reported sales of 154.71 billion Indian Rupees (US$2.36 billion) for the fiscal year ending March of 2016. This represents an increase of 4.4% versus 2015, when the company's sales were 148.19 billion Indian Rupees. Sales at Dr.Reddy's Laboratories Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 107%). Sales of Proprietary Products saw an increase that was more than double the company's growth rate: sales were up 162.5% in 2016, from 1.01 billion Indian Rupees to 2.66 billion Indian Rupees. Dr.Reddy's Laboratories Ltd also saw significant increases in sales in Generics (up 6.2% to 128.06 billion Indian Rupees) and Others (up 38.1% to 1.61 billion Indian Rupees) . Not all segments of Dr.Reddy's Laboratories Ltd experienced an increase in sales in 2016: sales of Active Pharmaceutical Ingredients and In fell 12.1% to 22.38 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dr.Reddy's Laboratories Ltd
  Stock Performance Chart for Dr.Reddy's Laboratories Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 2,628.35
(Figures in Indian Rupees)
1 Week -3.9%   13 Weeks -9.0%  
4 Weeks -12.3%   52 Weeks -13.8%  
Dr.Reddy's Laboratories Ltd Key Data:
  Ticker: DRREDDY Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 154,708,000,000
(Year Ending Jan 2017).
Employees: 22,175
  Currency: Indian Rupees Market Cap: 435,627,757,034
  Fiscal Yr Ends: March Shares Outstanding: 165,741,913
  Share Type: Ordinary Closely Held Shares: 43,848,700
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.